Santa Clara, CA, United States of America

Jagadeesh N Manda

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jagadeesh N Manda. Retrieved from https://idiyas.com/inventor/jagadeesh-n-manda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jagadeesh N Manda: Innovator in Phospholipid Compounds

Introduction

Jagadeesh N Manda is a notable inventor based in Santa Clara, CA. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of phospholipid compounds. His work focuses on innovative methods for treating viral infections.

Latest Patents

Jagadeesh N Manda holds a patent for "Phospholipid compounds and methods of making and using the same." This patent discloses phospholipid compounds and methods for using them, either alone or in combination with additional agents. The pharmaceutical formulations derived from these compounds are aimed at treating viral infections.

Career Highlights

Currently, Jagadeesh N Manda is employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role involves research and development in the area of viral infection treatments, where he applies his expertise in phospholipid compounds.

Collaborations

One of his notable coworkers is Michael O Clarke, with whom he collaborates on various projects related to pharmaceutical innovations.

Conclusion

Jagadeesh N Manda's contributions to the field of pharmaceutical formulations through his innovative work on phospholipid compounds highlight his importance as an inventor. His ongoing research continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…